$Aeglea BioTherapeutics, Inc.(AGLE)$ 8-K - Current report Filed: 2018-09-04 AccNo: 0001564590-18-022572 Size: 289 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接